Charity calls on NICE to reverse Opdivo rejection
Kidney Cancer UK is calling on the National Institute for Health and Care Excellence to reverse a preliminary decision to bar patients with kidney cancer from NHS access to the first immunotherapy approved for the disease.
Read More
